Score2 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Score2 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Score2 Trial Today - Breaking & Trending Today

Bevacizumab First-line Treatment More Cost-Effective in RVO vs Aflibercept

Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar. ....

Early Treatment Diabetic Retinopathy Study , Macular Edema , Anti Vegf , Score2 Trial ,